Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Novo Nordisk (GB:0TDD)
LSE:0TDD
Novo Nordisk (0TDD) Share Price & Analysis
8 Followers
0TDD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$74.99 - $142.20
Previous Close$122.79
Volume15.42K
Average Volume (3M)19.49K
Market Cap
$544.29B
Enterprise Value$543.83B
Total Cash (Recent Filing)kr30.23B
Total Debt (Recent Filing)kr27.01B
Price to Earnings (P/E)N/A
Beta0.68
Next Earnings
Aug 07, 2024EPS Estimate
$0.78Last Dividend Ex-Date
Mar 22, 2024Dividend Yield0.79%
Share Statistics
EPS (TTM)N/A
Shares Outstanding4,462,229,293
10 Day Avg. Volume17,945
30 Day Avg. Volume19,486
Standard Deviation0.05
R-Squared0.02
Alpha0.00878
Financial Highlights & Ratios
Price to Book (P/B)12.49
Price to Sales (P/S)4.84
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$151.40Price Target Upside23.30% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Novo Nordisk News
PremiumCompany Announcements
Novo Nordisk Q1 Sales and Profit Surge
PremiumCompany Announcements
Novo Nordisk Completes Share Buyback
Bulls Say, Bears Say
Bulls Say
Financial GuidanceRevenue and operating profit guidance were increased, signaling the company's confidence in its continued financial growth.
Product PerformanceKey products like Ozempic and Victoza continued to outperform in diabetes care, showing strength in the company's core market.
Strategic DevelopmentsThe partnership with Catalent for expanded manufacturing enables the company to meet the high demand in a capacity-constrained market, potentially increasing its market share.
Bears Say
Financial ForecastThe acquisition is expected to have a low single-digit negative impact on operating profit growth.
Product PerformanceObesity care missed expectations with Wegovy missing estimates by 10%.
RevenueObesity care revenue fell short of expectations with Wegovy missing estimates.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.00% Mutual Funds
1.76% Other Institutional Investors
98.24% Public Companies and
Individual Investors
0TDD FAQ
What was Novo Nordisk’s price range in the past 12 months?
Novo Nordisk lowest share price was $74.99 and its highest was $142.20 in the past 12 months.
What is Novo Nordisk’s market cap?
Currently, no data Available
When is Novo Nordisk’s upcoming earnings report date?
Novo Nordisk’s upcoming earnings report date is Aug 07, 2024 which is in 95 days.
How were Novo Nordisk’s earnings last quarter?
Novo Nordisk released its earnings results on May 02, 2024. The company reported $0.814 earnings per share for the quarter, beating the consensus estimate of $0.752 by $0.062.
Is Novo Nordisk overvalued?
According to Wall Street analysts Novo Nordisk’s price is currently Undervalued.
Does Novo Nordisk pay dividends?
Novo Nordisk pays a Semiannually dividend of $0.66 which represents an annual dividend yield of 0.79%. See more information on Novo Nordisk dividends here
What is Novo Nordisk’s EPS estimate?
Novo Nordisk’s EPS estimate is $0.78.
How many shares outstanding does Novo Nordisk have?
Currently, no data Available
What happened to Novo Nordisk’s price movement after its last earnings report?
Novo Nordisk reported an EPS of $0.814 in its last earnings report, beating expectations of $0.752. Following the earnings report the stock price went down -2.678%.
Which hedge fund is a major shareholder of Novo Nordisk?
Among the largest hedge funds holding Novo Nordisk’s share is Fisher Asset Management LLC. It holds Novo Nordisk’s shares valued at 1B.
---
Novo Nordisk Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$151.40 (23.30% Upside)
$151.40 (23.30% Upside)
Blogger Sentiment
Bullish
GB:0TDD Sentiment 87%
Sector Average 70%
Sector Average 70%
News Sentiment
Bullish
Bullish news 67%
Bearish news 33%
Bearish news 33%
Technicals
SMA
Positive
20 days / 200 days
Momentum
47.94%
12-Months-Change
Fundamentals
Return on Equity
99.99%
Trailing 12-Months
Asset Growth
18.69%
Trailing 12-Months
Company Description
Novo Nordisk
Novo Nordisk A/S is a Denmark-based healthcare company, which manufactures and markets pharmaceutical products globally. The company operates through two segments, including Diabetes & Obesity Care, and Biopharmaceuticals. The company was founded in 1925.
---
0TDD Company Deck
---
0TDD Earnings Call
Q1 2024
0:00 / 0:00
---
0TDD Stock 12 Months Forecast
Average Price Target
$151.40
▲(23.30% Upside)
Technical Analysis
Best Analysts Covering 0TDD
1 Year
1 Year Success Rate
4/5 ratings generated profit
1 Year Average Return
+24.70%
assigned a buy rating 2 months ago
Copying Michael Nedelcovych's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +24.70% per trade.
---